SCHEMBL6152908

SCHEMBL6152908

O=C(O)C=Cc1cncc(O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA3 P07451 3/20 0.52
CA4 P22748 3/20 0.52
CA6 P23280 3/20 0.52
CA5A P35218 3/20 0.52
CA7 P43166 3/20 0.52
CA9 Q16790 3/20 0.52
CA14 Q9ULX7 3/20 0.52
CA5B Q9Y2D0 3/20 0.52
PKM P14618 3/20 0.52
AKR1B10 O60218 2/20 0.52
AKR1B1 P15121 2/20 0.52
DPP4 P27487 2/20 0.52
HCAR2 Q8TDS4 2/20 0.52
ESR1 P03372 1/20 0.52
TYR P14679 1/20 0.52
ESR2 Q92731 1/20 0.52
KDM4E B2RXH2 7/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152906 1.00 CA12 (0.52) CA12CA1CA2CA3CA4
SCHEMBL27497376 0.83 PELI1 (0.46) ESR1KDM4EMAPK1APPMAPT
SCHEMBL12735947 0.80 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL746816 0.79 HCAR2 (0.48) CA12CA1CA2CA3CA4
SCHEMBL746977 0.79 HCAR2 (0.48) CA12CA1CA2CA3CA4
SCHEMBL5883944 0.79 HCAR2 (0.48) CA12CA1CA2CA3CA4
SCHEMBL5883952 0.79 HCAR2 (0.48) CA12CA1CA2CA3CA4
SCHEMBL9757067 0.79 HCAR2 (0.48) CA12CA1CA2CA3CA4
SCHEMBL9836170 0.79 HCAR2 (0.48) CA12CA1CA2CA3CA4
SCHEMBL9757071 0.79 HCAR2 (0.48) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1233964-B1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2005-06-22 EP disclosed
US-6683090-B1 N-(1-AZABICYCLO(2.2.2)OCT-3-YL)PROPENAMIDE DERIVATIVES; PSYCHOTIC AND INTELLECTUAL IMPAIRMENT DISORDERS ASTRAZENECA AB (SE) 2004-01-27 US disclosed
EP-1233964-A1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES AstraZeneca AB (SE) 2002-08-28 EP disclosed
WO-2001036417-A1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2001-05-25 WO disclosed